Skip to main content

Long road ahead for Iran’s medicinal plants industry

Once the world’s top exporter of medicinal plants, Iran now faces a multitude of obstacles to keep this industry on track.
SHAHN ABAD, IRAN:  TO GO WITH AFP STORY "IRAN-FARM-ECONOMY-LUXURY-SAFFRON" Iranian women wearing chadors pick saffron flowers on a farm in Shahn Abad village, near the town of Torbat-e Heydarieh, northeast of Iran, 31 October 2006. Despite Iran's status as the undisputed heavyweight champion of the saffron world, it has yet to realize the full economic potential of the 3,000 year-old industry and faces challenges to hold on to its rampant market share. MORE IMAGES AVAILABLE ON IMAGE FORUM AFP PHOTO/BEHROUZ

TEHRAN, Iran — The world has seen great advances in medicine in recent centuries, leading to the discovery and manufacture of numerous types of drugs to cure diseases. Yet many around the world still prefer to use plants and natural products to improve their health, mainly to avoid side effects caused by chemical drugs. As a result, the production of medicinal plants has emerged as a new industry, with their exports rising over the past several decades. According to the United Nations Food and Agriculture Organization (FAO), global sales of such herbal medicine products were estimated at $60 billion in 2002. The figure jumped to $150 billion in 2013 and this trajectory is set to continue in coming decades.

In Iran, however, things are different. Exports of medicinal plants have declined in the past two decades, even though the country is home to 8,000 plant species, of which more than 2,300 have medicinal properties. A whopping 1,728 of them are endemic to Iran.

Access the Middle East news and analysis you can trust

Join our community of Middle East readers to experience all of Al-Monitor, including 24/7 news, analyses, memos, reports and newsletters.

Subscribe

Only $100 per year.